Patent Application
Provisional
Small
App. No. 61/692,828
· Confirmation No. 3062
Antiangiogenic Gene Therapy with Soluble VEGF-receptors -1, -2 and -3 Together with Paclitaxel Prolongs Survival of Mice with Human Ovarian Carcinoma
Inventor:
Seppo Yla-Herttuala
Provisional Application Expired
Inventors
Seppo Yla-Herttuala
Kuopio, FINLAND
Attorneys & Agents of Record
Prosecution
- Customer No.
- 22925
- Docket No.
- FKD
- Confirmation No.
- 3062
Child
Claims priority from a provisional application
→
App. 13/969,763
Filed 2013-08-19
· Abandoned -- Failure to Respond to an Office Action
Child
Claims priority from a provisional application
→
App. 17/955,417
Filed 2022-09-28
· Abandoned -- Failure to Respond to an Office Action
Child
Claims priority from a provisional application
→
App. 16/364,284
Filed 2019-03-26
· Abandoned -- Failure to Respond to an Office Action
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 61/692,828
- Filed
- 2012-08-24
External Links